Skip to main navigation Skip to search Skip to main content

Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial

  • Blair V. Landon
  • , Julia L. Boland
  • , Andrea E. Wahner Hendrickson
  • , Deborah K. Armstrong
  • , Boris Winterhoff
  • , Jaime Wehr
  • , Akshaya V. Annapragada
  • , Christopher Cherry
  • , Archana Balan
  • , Guneet Kaleka
  • , Victor E. Velculescu
  • , Stephen B. Baylin
  • , Cynthia A. Zahnow
  • , Dennis J. Slamon
  • , Gottfried E. Konecny
  • , Valsamo Anagnostou
  • , John A. Glaspy

Research output: Contribution to journal › Article › peer-review

3   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry